Healthcare Sector Stocks
The Healthcare sector has a total of 1058 stocks, with a combined market cap of $9.11 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 45.78.
Market Cap
9.11T
Revenue
4.59T
Profits
199.02B
PE Ratio
45.78
Profit Margin
4.34%
Dividend Yield
0.38%
1059 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.08T | 0.06% | 1,484,086 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 623.45B | -1.67% | 4,746,450 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 441.82B | -1.06% | 3,830,360 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 391.71B | 1.35% | 3,610,489 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 308.93B | -0.72% | 5,332,127 | 65.77B |
| 6 | NVS | Novartis AG | 282.06B | -0.30% | 2,131,254 | 56.58B |
| 7 | AZN | AstraZeneca PLC | 277.49B | -5.74% | 6,311,574 | 60.44B |
| 8 | NVO | Novo Nordisk A/S | 218.12B | 0.06% | 4,230,913 | 50.57B |
| 9 | AMGN | Amgen Inc. | 196.20B | -1.21% | 1,129,651 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 194.87B | 2.80% | 940,216 | 45.20B |
| 11 | GILD | Gilead Sciences, Inc. | 167.41B | -0.72% | 3,734,218 | 29.74B |
| 12 | ABT | Abbott Laboratories | 163.99B | -1.08% | 4,879,635 | 45.13B |
| 13 | ISRG | Intuitive Surgical, Inc. | 145.73B | -0.87% | 1,438,379 | 10.58B |
| 14 | DHR | Danaher Corporation | 138.58B | 2.64% | 1,986,286 | 24.78B |
| 15 | PFE | Pfizer Inc. | 138.21B | 0.83% | 22,940,493 | 63.32B |
| 16 | CVS | CVS Health Corporation | 130.92B | -1.78% | 5,670,753 | 405.62B |
| 17 | VRTX | Vertex Pharmaceuticals Incorporated | 125.99B | -0.41% | 1,417,994 | 12.22B |
| 18 | SYK | Stryker Corporation | 125.36B | 0.04% | 1,479,897 | 25.27B |
| 19 | BMY | Bristol-Myers Squibb Company | 118.26B | 0.64% | 5,112,103 | 48.48B |
| 20 | GSK | GSK plc | 105.41B | -0.09% | 2,202,788 | 43.29B |
| 21 | MDT | Medtronic plc | 105.33B | 0.34% | 3,754,003 | 36.36B |
| 22 | SNY | Sanofi | 103.14B | 2.63% | 3,948,956 | 54.60B |
| 23 | MCK | McKesson Corporation | 92.82B | -3.16% | 716,412 | 403.43B |
| 24 | ELV | Elevance Health, Inc. | 91.13B | 0.86% | 786,718 | 200.42B |
| 25 | HCA | HCA Healthcare, Inc. | 90.71B | -0.42% | 870,565 | 76.39B |
| 26 | CI | The Cigna Group | 77.02B | 0.49% | 848,087 | 277.89B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 67.96B | 0.77% | 443,201 | 14.92B |
| 28 | BSX | Boston Scientific Corporation | 66.81B | 0.31% | 10,048,613 | 20.61B |
| 29 | COR | Cencora, Inc. | 58.82B | -2.35% | 1,187,399 | 328.68B |
| 30 | ARGX | argenx SE | 56.64B | -0.53% | 257,622 | 4.74B |
| 31 | CAH | Cardinal Health, Inc. | 54.74B | -1.44% | 1,739,347 | 250.74B |
| 32 | MDLN | Medline Inc. | 53.68B | 1.40% | 2,281,575 | 29.14B |
| 33 | EW | Edwards Lifesciences Corporation | 52.60B | -2.45% | 4,502,267 | 6.30B |
| 34 | TAK | Takeda Pharmaceutical Company Limited | 52.53B | -0.78% | 2,217,796 | 28.34B |
| 35 | HUM | Humana Inc. | 47.74B | 0.34% | 838,803 | 137.20B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 44.06B | 0.51% | 475,401 | 4.45B |
| 37 | HLN | Haleon plc | 42.54B | -0.26% | 7,735,646 | 14.85B |
| 38 | ALNY | Alnylam Pharmaceuticals, Inc. | 41.66B | -3.55% | 5,572,326 | 4.29B |
| 39 | BDX | Becton, Dickinson and Company | 41.54B | 0.13% | 1,328,108 | 22.23B |
| 40 | RVMD | Revolution Medicines, Inc. | 40.60B | 0.64% | 1,051,452 | - |
| 41 | NTRA | Natera, Inc. | 40.38B | 2.76% | 944,111 | 2.50B |
| 42 | TEVA | Teva Pharmaceutical Industries Limited | 38.51B | -0.51% | 3,954,026 | 17.35B |
| 43 | A | Agilent Technologies, Inc. | 37.71B | 3.46% | 1,600,085 | 7.23B |
| 44 | WAT | Waters Corporation | 36.96B | 2.25% | 374,377 | 3.77B |
| 45 | IQV | IQVIA Holdings Inc. | 34.89B | 2.59% | 816,671 | 16.63B |
| 46 | ONC | BeOne Medicines AG | 33.73B | 0.49% | 102,744 | 5.74B |
| 47 | RPRX | Royalty Pharma plc | 33.38B | -0.69% | 2,319,294 | 2.44B |
| 48 | CNC | Centene Corporation | 33.37B | 0.72% | 1,716,262 | 178.33B |
| 49 | ALC | Alcon Inc. | 32.67B | 0.77% | 1,229,240 | 10.63B |
| 50 | ZTS | Zoetis Inc. | 31.48B | -0.03% | 2,776,740 | 9.53B |
| 51 | VEEV | Veeva Systems Inc. | 30.82B | 0.82% | 960,844 | 3.32B |
| 52 | MRNA | Moderna, Inc. | 30.40B | 3.81% | 3,719,967 | 2.23B |
| 53 | RMD | ResMed Inc. | 30.10B | 1.37% | 1,201,420 | 5.54B |
| 54 | GEHC | GE HealthCare Technologies Inc. | 29.44B | 0.06% | 2,062,916 | 20.98B |
| 55 | BIIB | Biogen Inc. | 29.36B | -0.75% | 1,099,348 | 9.94B |
| 56 | ILMN | Illumina, Inc. | 29.29B | 3.09% | 1,510,975 | 4.39B |
| 57 | DXCM | DexCom, Inc. | 28.20B | -1.32% | 2,695,635 | 4.82B |
| 58 | ROIV | Roivant Sciences Ltd. | 26.48B | 2.02% | 3,464,628 | 8.26M |
| 59 | MTD | Mettler-Toledo International Inc. | 26.04B | 3.19% | 71,480 | 4.09B |
| 60 | PHG | Koninklijke Philips N.V. | 26.03B | -1.09% | 967,651 | 20.34B |
| 61 | INSM | Insmed Incorporated | 25.63B | 1.48% | 2,048,053 | 819.56M |
| 62 | WST | West Pharmaceutical Services, Inc. | 25.27B | 1.14% | 354,505 | 3.22B |
| 63 | INCY | Incyte Corporation | 23.68B | 1.07% | 891,693 | 5.36B |
| 64 | BNTX | BioNTech SE | 23.52B | -0.56% | 733,236 | 3.23B |
| 65 | UTHR | United Therapeutics Corporation | 23.42B | -0.47% | 215,437 | 3.17B |
| 66 | DGX | Quest Diagnostics Incorporated | 23.01B | -0.16% | 427,456 | 11.28B |
| 67 | LH | Labcorp Holdings Inc. | 22.76B | -0.06% | 269,197 | 14.14B |
| 68 | GH | Guardant Health, Inc. | 21.78B | 5.19% | 3,142,369 | 1.08B |
| 69 | STE | STERIS plc | 21.03B | 3.01% | 910,932 | 5.94B |
| 70 | VTRS | Viatris Inc. | 19.03B | -1.92% | 6,765,943 | 14.56B |
| 71 | NBIX | Neurocrine Biosciences, Inc. | 18.18B | 1.46% | 959,066 | 3.10B |
| 72 | GMAB | Genmab A/S | 18.12B | 0.86% | 2,629,350 | 3.90B |
| 73 | THC | Tenet Healthcare Corporation | 17.81B | 0.27% | 677,424 | 21.46B |
| 74 | BBIO | BridgeBio Pharma, Inc. | 17.66B | 15.01% | 18,806,445 | 579.96M |
| 75 | ZBH | Zimmer Biomet Holdings, Inc. | 17.28B | 2.02% | 1,018,592 | 8.41B |
| 76 | ASND | Ascendis Pharma A/S | 17.09B | -0.75% | 557,795 | 998.25M |
| 77 | JAZZ | Jazz Pharmaceuticals plc | 15.54B | -0.38% | 481,641 | 4.44B |
| 78 | MEDP | Medpace Holdings, Inc. | 15.26B | 0.46% | 337,706 | 2.68B |
| 79 | BTSG | BrightSpring Health Services, Inc. | 14.92B | 1.59% | 1,593,821 | 13.65B |
| 80 | DVA | DaVita Inc. | 14.74B | -0.52% | 589,436 | 13.84B |
| 81 | EXEL | Exelixis, Inc. | 14.35B | 1.76% | 1,291,090 | 2.38B |
| 82 | COO | The Cooper Companies, Inc. | 13.86B | 2.07% | 1,746,520 | 4.23B |
| 83 | SOLV | Solventum Corporation | 13.16B | 1.12% | 573,543 | 8.26B |
| 84 | ICLR | ICON Public Limited Company | 12.93B | 2.01% | 449,450 | 8.27B |
| 85 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.89B | -1.11% | 202,971 | 1.13B |
| 86 | AXSM | Axsome Therapeutics, Inc. | 12.81B | 1.34% | 518,831 | 708.24M |
| 87 | FMS | Fresenius Medical Care AG | 12.79B | -0.10% | 356,673 | 22.32B |
| 88 | SNN | Smith & Nephew plc | 12.77B | 1.35% | 1,305,324 | 6.16B |
| 89 | ALGN | Align Technology, Inc. | 12.74B | 1.81% | 514,001 | 4.10B |
| 90 | RVTY | Revvity, Inc. | 12.58B | 3.13% | 1,318,717 | 2.90B |
| 91 | PEN | Penumbra, Inc. | 12.51B | 0.21% | 101,012 | 1.45B |
| 92 | ELAN | Elanco Animal Health Incorporated | 12.29B | -0.34% | 2,851,725 | 4.89B |
| 93 | MOH | Molina Healthcare, Inc. | 12.09B | 0.51% | 552,628 | 43.10B |
| 94 | SMMT | Summit Therapeutics Inc. | 12.02B | -1.27% | 1,713,761 | - |
| 95 | ABVX | ABIVAX Société Anonyme | 12.00B | 1.53% | 839,171 | 5.67M |
| 96 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.83B | -2.06% | 1,099,565 | 622.01M |
| 97 | CYTK | Cytokinetics, Incorporated | 11.68B | 1.37% | 1,260,135 | 105.82M |
| 98 | BAX | Baxter International Inc. | 11.60B | 2.18% | 2,984,097 | 11.32B |
| 99 | BMRN | BioMarin Pharmaceutical Inc. | 11.59B | 0.35% | 656,747 | 3.24B |
| 100 | CRL | Charles River Laboratories International, Inc. | 11.25B | 4.32% | 506,394 | 4.03B |
| 101 | TECH | Bio-Techne Corporation | 11.09B | 0.31% | 2,950,573 | 1.21B |
| 102 | RDY | Dr. Reddy's Laboratories Limited | 11.08B | -1.66% | 4,767,123 | 3.58B |
| 103 | TEM | Tempus AI, Inc. | 11.04B | 7.39% | 4,115,389 | 1.36B |
| 104 | EHC | Encompass Health Corporation | 11.00B | 0.55% | 466,578 | 6.07B |
| 105 | PODD | Insulet Corporation | 10.96B | 0.53% | 866,857 | 2.90B |
| 106 | KRYS | Krystal Biotech, Inc. | 10.94B | -1.11% | 196,923 | 417.30M |
| 107 | IONS | Ionis Pharmaceuticals, Inc. | 10.62B | -23.88% | 19,631,988 | 1.06B |
| 108 | GMED | Globus Medical, Inc. | 10.40B | 0.58% | 1,778,483 | 3.10B |
| 109 | APGE | Apogee Therapeutics, Inc. | 10.01B | 0.20% | 1,180,689 | - |
| 110 | CORT | Corcept Therapeutics Incorporated | 10.00B | 0.25% | 964,767 | 769.10M |
| 111 | NUVL | Nuvalent, Inc. | 9.82B | 0.03% | 1,205,634 | - |
| 112 | ENSG | The Ensign Group, Inc. | 9.80B | -0.52% | 321,334 | 5.27B |
| 113 | KYMR | Kymera Therapeutics, Inc. | 9.70B | 3.29% | 465,767 | 51.48M |
| 114 | HSIC | Henry Schein, Inc. | 9.54B | 0.64% | 914,493 | 13.38B |
| 115 | OSCR | Oscar Health, Inc. | 9.40B | 1.27% | 2,016,961 | 13.30B |
| 116 | UHS | Universal Health Services, Inc. | 9.39B | -0.84% | 462,294 | 17.76B |
| 117 | PRAX | Praxis Precision Medicines, Inc. | 9.32B | 0.38% | 206,761 | 7.46M |
| 118 | HALO | Halozyme Therapeutics, Inc. | 9.31B | -2.29% | 1,428,258 | 1.51B |
| 119 | IBRX | ImmunityBio, Inc. | 9.29B | 0.80% | 9,632,023 | 140.98M |
| 120 | BRKR | Bruker Corporation | 9.21B | 5.74% | 1,369,874 | 3.46B |
| 121 | GKOS | Glaukos Corporation | 9.09B | 1.18% | 662,339 | 551.35M |
| 122 | ALKS | Alkermes plc | 8.96B | -0.95% | 1,314,800 | 1.56B |
| 123 | PTGX | Protagonist Therapeutics, Inc. | 8.86B | -1.70% | 392,971 | 74.06M |
| 124 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.82B | 0.14% | 8,324,356 | 18.07M |
| 125 | QGEN | Qiagen N.V. | 8.68B | 10.49% | 12,183,946 | 2.10B |
| 126 | PCVX | Vaxcyte, Inc. | 8.64B | 1.91% | 1,019,335 | - |
| 127 | SYRE | Spyre Therapeutics, Inc. | 8.59B | 3.63% | 1,142,650 | - |
| 128 | IMVT | Immunovant, Inc. | 8.43B | 1.81% | 845,820 | - |
| 129 | TGTX | TG Therapeutics, Inc. | 8.40B | 3.56% | 1,199,094 | 700.35M |
| 130 | HIMS | Hims & Hers Health, Inc. | 8.23B | -1.44% | 7,527,831 | 2.37B |
| 131 | RGEN | Repligen Corporation | 8.13B | 4.84% | 451,811 | 763.34M |
| 132 | ATR | AptarGroup, Inc. | 7.95B | 0.31% | 207,646 | 3.87B |
| 133 | BIO | Bio-Rad Laboratories, Inc. | 7.93B | 4.44% | 164,459 | 2.59B |
| 134 | HQY | HealthEquity, Inc. | 7.91B | -0.06% | 589,646 | 1.34B |
| 135 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.90B | 0.77% | 471,048 | 217.17M |
| 136 | MIRM | Mirum Pharmaceuticals, Inc. | 7.78B | -0.80% | 462,280 | 569.61M |
| 137 | PTCT | PTC Therapeutics, Inc. | 7.42B | 1.03% | 955,395 | 827.11M |
| 138 | LQDA | Liquidia Corporation | 7.25B | 2.55% | 617,306 | 288.07M |
| 139 | AVTR | Avantor, Inc. | 7.18B | 7.79% | 7,513,838 | 6.55B |
| 140 | HNGE | Hinge Health, Inc. | 6.96B | 1.67% | 879,786 | 646.34M |
| 141 | SRRK | Scholar Rock Holding Corporation | 6.95B | 3.46% | 640,546 | - |
| 142 | PACS | PACS Group, Inc. | 6.93B | -0.59% | 358,397 | 5.43B |
| 143 | COGT | Cogent Biosciences, Inc. | 6.91B | 1.20% | 3,534,605 | - |
| 144 | LNTH | Lantheus Holdings, Inc. | 6.91B | -0.64% | 405,848 | 1.55B |
| 145 | XENE | Xenon Pharmaceuticals Inc. | 6.86B | 1.49% | 2,306,241 | 7.50M |
| 146 | CHE | Chemed Corporation | 6.48B | 2.24% | 99,738 | 2.54B |
| 147 | CGON | CG Oncology, Inc. | 6.47B | 5.08% | 668,459 | 5.07M |
| 148 | DFTX | Definium Therapeutics, Inc. | 6.42B | 6.79% | 2,725,274 | - |
| 149 | LGND | Ligand Pharmaceuticals Incorporated | 6.41B | 2.68% | 357,114 | 274.48M |
| 150 | GRFS | Grifols, S.A. | 6.21B | -0.21% | 531,349 | 8.58B |
| 151 | BLCO | Bausch + Lomb Corporation | 5.96B | 0.36% | 202,002 | 5.21B |
| 152 | ERAS | Erasca, Inc. | 5.96B | 1.54% | 3,592,337 | - |
| 153 | BLTE | Belite Bio, Inc | 5.96B | -0.60% | 107,689 | - |
| 154 | TFX | Teleflex Incorporated | 5.94B | 3.01% | 308,884 | 2.13B |
| 155 | BLLN | BillionToOne, Inc. | 5.89B | 6.27% | 727,321 | 354.54M |
| 156 | TWST | Twist Bioscience Corporation | 5.83B | 4.72% | 1,054,219 | 409.48M |
| 157 | CELC | Celcuity Inc. | 5.53B | 4.15% | 879,139 | - |
| 158 | DNTH | Dianthus Therapeutics, Inc. | 5.47B | 2.00% | 1,904,694 | 1.34M |
| 159 | TXG | 10x Genomics, Inc. | 5.45B | 14.52% | 2,512,026 | 638.78M |
| 160 | TVTX | Travere Therapeutics, Inc. | 5.43B | 0.14% | 1,058,135 | 536.20M |
| 161 | AMRX | Amneal Pharmaceuticals, Inc. | 5.43B | 0.38% | 1,202,163 | 3.05B |
| 162 | CRSP | CRISPR Therapeutics AG | 5.43B | -4.91% | 1,244,134 | 4.10M |
| 163 | STVN | Stevanato Group S.p.A. | 5.39B | 2.23% | 235,170 | 1.39B |
| 164 | LEGN | Legend Biotech Corporation | 5.30B | -1.61% | 1,242,352 | 1.14B |
| 165 | ORKA | Oruka Therapeutics, Inc. | 5.29B | 3.91% | 466,637 | - |
| 166 | SHC | Sotera Health Company | 5.24B | 5.15% | 2,861,285 | 1.19B |
| 167 | MANE | Veradermics, Incorporated | 5.22B | 5.61% | 245,853 | - |
| 168 | RDNT | RadNet, Inc. | 5.20B | 0.75% | 359,044 | 2.14B |
| 169 | EWTX | Edgewise Therapeutics, Inc. | 5.17B | 3.76% | 1,393,610 | - |
| 170 | CAI | Caris Life Sciences, Inc. | 5.05B | 3.23% | 2,855,649 | 907.29M |
| 171 | INDV | Indivior Pharmaceuticals, Inc. | 5.04B | 1.03% | 953,995 | 1.29B |
| 172 | KNSA | Kiniksa Pharmaceuticals International, plc | 5.03B | 1.02% | 598,975 | 754.05M |
| 173 | VKTX | Viking Therapeutics, Inc. | 4.77B | 2.90% | 1,465,042 | - |
| 174 | VCYT | Veracyte, Inc. | 4.73B | 5.67% | 486,509 | 541.74M |
| 175 | LIVN | LivaNova PLC | 4.54B | 0.07% | 487,381 | 1.43B |
| 176 | RLAY | Relay Therapeutics, Inc. | 4.53B | 5.86% | 3,429,864 | 10.68M |
| 177 | ACAD | ACADIA Pharmaceuticals Inc. | 4.52B | 1.46% | 1,430,279 | 1.10B |
| 178 | WAY | Waystar Holding Corp. | 4.45B | 2.02% | 1,856,506 | 1.16B |
| 179 | TNGX | Tango Therapeutics, Inc. | 4.41B | -0.46% | 2,382,722 | 56.99M |
| 180 | ALHC | Alignment Healthcare, Inc. | 4.35B | 4.94% | 6,357,633 | 4.26B |
| 181 | DNLI | Denali Therapeutics Inc. | 4.33B | 2.14% | 1,294,935 | - |
| 182 | MMSI | Merit Medical Systems, Inc. | 4.26B | 0.52% | 330,639 | 1.54B |
| 183 | MMED | MiniMed Group, Inc. | 4.23B | 0.27% | 412,972 | 3.10B |
| 184 | NAMS | NewAmsterdam Pharma Company N.V. | 4.20B | 0.28% | 482,453 | 22.57M |
| 185 | NVST | Envista Holdings Corporation | 4.19B | - | 3,914,394 | 2.81B |
| 186 | LFST | LifeStance Health Group, Inc. | 4.18B | 2.86% | 1,980,597 | 1.49B |
| 187 | DOCS | Doximity, Inc. | 4.03B | 1.57% | 1,241,162 | 644.86M |
| 188 | CON | Concentra Group Holdings Parent, Inc. | 4.02B | -0.10% | 405,655 | 2.23B |
| 189 | DYN | Dyne Therapeutics, Inc. | 4.01B | 1.78% | 1,252,458 | - |
| 190 | TLX | Telix Pharmaceuticals Limited | 3.97B | 1.99% | 146,122 | 803.79M |
| 191 | GPCR | Structure Therapeutics Inc. | 3.93B | 0.66% | 405,475 | - |
| 192 | ICUI | ICU Medical, Inc. | 3.89B | 2.40% | 124,358 | 2.16B |
| 193 | IRTC | iRhythm Holdings, Inc. | 3.88B | -5.80% | 585,957 | 787.85M |
| 194 | ALMS | Alumis Inc. | 3.87B | 2.15% | 1,482,776 | 8.40M |
| 195 | PBLS | Parabilis Medicines, Inc. | 3.87B | -1.48% | 298,167 | - |
| 196 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.85B | 0.02% | 815,231 | 596.96M |
| 197 | RCUS | Arcus Biosciences, Inc. | 3.77B | -0.86% | 572,852 | 236.00M |
| 198 | BKD | Brookdale Senior Living Inc. | 3.65B | 1.97% | 2,491,071 | 3.00B |
| 199 | ELVN | Enliven Therapeutics, Inc. | 3.64B | 2.73% | 630,906 | - |
| 200 | ARQT | Arcutis Biotherapeutics, Inc. | 3.60B | 1.02% | 1,409,400 | 415.62M |
| 201 | WRBY | Warby Parker Inc. | 3.59B | 5.85% | 1,063,622 | 890.57M |
| 202 | BEAM | Beam Therapeutics Inc. | 3.56B | -2.93% | 2,194,449 | 164.01M |
| 203 | OGN | Organon & Co. | 3.55B | 0.22% | 771,392 | 6.16B |
| 204 | IDYA | IDEAYA Biosciences, Inc. | 3.54B | -1.80% | 775,951 | 225.27M |
| 205 | PRVA | Privia Health Group, Inc. | 3.50B | 2.17% | 860,387 | 2.25B |
| 206 | ADPT | Adaptive Biotechnologies Corporation | 3.49B | 8.23% | 2,198,305 | 295.41M |
| 207 | HAE | Haemonetics Corporation | 3.41B | 1.67% | 291,527 | 1.33B |
| 208 | OPCH | Option Care Health, Inc. | 3.41B | 1.02% | 1,320,694 | 5.67B |
| 209 | RARE | Ultragenyx Pharmaceutical Inc. | 3.39B | -0.29% | 1,653,662 | 670.00M |
| 210 | NHC | National HealthCare Corporation | 3.31B | -0.01% | 87,653 | 1.53B |
| 211 | GRAL | GRAIL, Inc. | 3.24B | 7.78% | 551,265 | 156.12M |
| 212 | ITGR | Integer Holdings Corporation | 3.13B | 1.06% | 272,665 | 1.86B |
| 213 | MBX | MBX Biosciences, Inc. | 3.12B | 6.19% | 651,013 | - |
| 214 | CLDX | Celldex Therapeutics, Inc. | 3.06B | - | 457,811 | 865.00K |
| 215 | QURE | uniQure N.V. | 3.06B | 2.25% | 1,006,968 | 18.09M |
| 216 | VERA | Vera Therapeutics, Inc. | 3.05B | 0.02% | 2,155,922 | - |
| 217 | IRON | Disc Medicine, Inc. | 3.02B | -1.19% | 226,312 | - |
| 218 | RGC | Regencell Bioscience Holdings Limited | 3.01B | -6.47% | 547,819 | - |
| 219 | ACHC | Acadia Healthcare Company, Inc. | 2.89B | 2.05% | 2,102,514 | 3.37B |
| 220 | SUPN | Supernus Pharmaceuticals, Inc. | 2.83B | -3.40% | 1,073,031 | 776.83M |
| 221 | TARS | Tarsus Pharmaceuticals, Inc. | 2.76B | -5.27% | 1,987,278 | 535.08M |
| 222 | IMNM | Immunome, Inc. | 2.74B | 0.75% | 1,010,213 | 4.02M |
| 223 | KLRA | Kailera Therapeutics, Inc. | 2.73B | -3.31% | 599,029 | - |
| 224 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.73B | -3.47% | 2,926,542 | 885.72M |
| 225 | SLS | SELLAS Life Sciences Group, Inc. | 2.66B | -1.85% | 6,617,856 | - |
| 226 | TRVI | Trevi Therapeutics, Inc. | 2.62B | -0.91% | 1,300,678 | - |
| 227 | ESTA | Establishment Labs Holdings Inc. | 2.61B | 0.81% | 245,873 | 229.58M |
| 228 | GRDN | Guardian Pharmacy Services, Inc. | 2.60B | 1.49% | 218,041 | 1.46B |
| 229 | NRIX | Nurix Therapeutics, Inc. | 2.56B | 1.69% | 966,302 | 71.78M |
| 230 | MLYS | Mineralys Therapeutics, Inc. | 2.55B | -4.70% | 1,109,904 | - |
| 231 | AGIO | Agios Pharmaceuticals, Inc. | 2.54B | -0.04% | 377,273 | 66.05M |
| 232 | TMDX | TransMedics Group, Inc. | 2.52B | 3.41% | 439,909 | 635.89M |
| 233 | BHVN | Biohaven Ltd. | 2.51B | 0.18% | 1,741,424 | - |
| 234 | PHVS | Pharvaris N.V. | 2.50B | -0.40% | 1,676,305 | - |
| 235 | KOD | Kodiak Sciences Inc. | 2.50B | -1.60% | 686,812 | - |
| 236 | CLOV | Clover Health Investments, Corp. | 2.47B | 0.75% | 4,215,872 | 2.21B |
| 237 | VCEL | Vericel Corporation | 2.46B | 2.55% | 311,783 | 292.09M |
| 238 | NKTR | Nektar Therapeutics | 2.46B | 1.24% | 454,282 | 55.63M |
| 239 | PGNY | Progyny, Inc. | 2.43B | 0.98% | 802,369 | 1.29B |
| 240 | HTFL | HeartFlow, Inc. | 2.39B | 6.16% | 902,339 | 191.42M |
| 241 | XRAY | DENTSPLY SIRONA Inc. | 2.39B | 1.10% | 3,365,136 | 3.68B |
| 242 | LMAT | LeMaitre Vascular, Inc. | 2.34B | 0.42% | 134,093 | 256.28M |
| 243 | ASTH | Astrana Health, Inc. | 2.32B | 1.04% | 442,717 | 3.53B |
| 244 | AXGN | Axogen, Inc. | 2.32B | 1.96% | 1,323,575 | 238.11M |
| 245 | OCUL | Ocular Therapeutix, Inc. | 2.31B | 2.58% | 2,082,958 | 52.04M |
| 246 | PBH | Prestige Consumer Healthcare Inc. | 2.29B | 0.27% | 340,904 | 1.09B |
| 247 | ZLAB | Zai Lab Limited | 2.25B | 1.19% | 794,508 | 453.28M |
| 248 | ABCL | AbCellera Biologics Inc. | 2.24B | 3.10% | 5,216,535 | 79.21M |
| 249 | VRDN | Viridian Therapeutics, Inc. | 2.23B | 1.66% | 1,602,911 | 70.92M |
| 250 | HRMY | Harmony Biosciences Holdings, Inc. | 2.21B | 0.26% | 449,984 | 899.11M |
| 251 | SNDX | Syndax Pharmaceuticals, Inc. | 2.20B | 0.90% | 1,197,317 | 217.17M |
| 252 | SGRY | Surgery Partners, Inc. | 2.17B | 1.67% | 980,094 | 3.34B |
| 253 | SRPT | Sarepta Therapeutics, Inc. | 2.17B | 1.68% | 2,653,830 | 2.18B |
| 254 | NTLA | Intellia Therapeutics, Inc. | 2.16B | -8.25% | 6,907,535 | 66.09M |
| 255 | MD | Pediatrix Medical Group, Inc. | 2.16B | 0.37% | 548,009 | 1.93B |
| 256 | PVLA | Palvella Therapeutics, Inc. | 2.15B | 3.27% | 119,634 | - |
| 257 | ADMA | ADMA Biologics, Inc. | 2.15B | 1.15% | 1,414,442 | 509.86M |
| 258 | KARD | Kardigan, Inc. | 2.14B | 7.97% | 224,625 | - |
| 259 | AVAH | Aveanna Healthcare Holdings Inc. | 2.14B | 2.29% | 2,025,135 | 2.52B |
| 260 | AUPH | Aurinia Pharmaceuticals Inc. | 2.14B | 2.34% | 1,262,960 | 298.30M |
| 261 | NUVB | Nuvation Bio Inc. | 2.13B | 4.09% | 8,114,486 | 143.05M |
| 262 | NEOG | Neogen Corporation | 2.13B | 5.45% | 1,065,343 | 870.56M |
| 263 | TSHA | Taysha Gene Therapies, Inc. | 2.10B | 1.23% | 1,802,981 | 7.47M |
| 264 | BFLY | Butterfly Network, Inc. | 2.10B | 9.13% | 8,651,698 | 102.92M |
| 265 | OMCL | Omnicell, Inc. | 2.07B | 0.98% | 465,121 | 1.23B |
| 266 | GLUE | Monte Rosa Therapeutics, Inc. | 2.07B | 1.79% | 991,979 | 42.95M |
| 267 | WGS | GeneDx Holdings Corp. | 2.06B | 5.96% | 521,102 | 442.68M |
| 268 | AMLX | Amylyx Pharmaceuticals, Inc. | 2.04B | 2.80% | 783,498 | -665.00K |
| 269 | STOK | Stoke Therapeutics, Inc. | 2.04B | 0.43% | 294,521 | 32.08M |
| 270 | SION | Sionna Therapeutics, Inc. | 2.02B | 1.68% | 535,152 | - |
| 271 | LKFT | Lakefront Biotherapeutics NV | 2.01B | -0.68% | 105,602 | 1.20B |
| 272 | GENB | Generate Biomedicines, Inc. | 2.01B | -1.13% | 449,863 | 30.30M |
| 273 | RAPP | Rapport Therapeutics, Inc. | 2.01B | 0.14% | 262,004 | 20.00M |
| 274 | NVCR | NovoCure Limited | 2.00B | -0.46% | 750,206 | 674.41M |
| 275 | ADUS | Addus HomeCare Corporation | 2.00B | 2.90% | 287,735 | 1.45B |
| 276 | RXRX | Recursion Pharmaceuticals, Inc. | 2.00B | 1.21% | 20,791,583 | 66.41M |
| 277 | NBTX | Nanobiotix S.A. | 1.98B | 0.95% | 38,410 | 38.27M |
| 278 | ATAI | AtaiBeckley Inc. | 1.97B | 3.48% | 6,892,544 | 3.49M |
| 279 | PGEN | Precigen, Inc. | 1.97B | -0.72% | 2,598,680 | 31.60M |
| 280 | ANAB | AnaptysBio, Inc. | 1.97B | 1.67% | 283,372 | 232.39M |
| 281 | UFPT | UFP Technologies, Inc. | 1.97B | 1.03% | 275,469 | 608.85M |
| 282 | TYRA | Tyra Biosciences, Inc. | 1.96B | 1.38% | 487,568 | - |
| 283 | URGN | UroGen Pharma Ltd. | 1.96B | 5.89% | 521,724 | 140.49M |
| 284 | HCM | HUTCHMED (China) Limited | 1.96B | 0.54% | 20,989 | 548.51M |
| 285 | BCAX | Bicara Therapeutics Inc. | 1.96B | 2.79% | 358,528 | - |
| 286 | IOVA | Iovance Biotherapeutics, Inc. | 1.95B | 1.99% | 12,931,717 | 285.61M |
| 287 | ABSI | Absci Corporation | 1.94B | 3.24% | 4,404,660 | 1.84M |
| 288 | ZYME | Zymeworks Inc. | 1.94B | 1.50% | 403,714 | 81.26M |
| 289 | NEO | NeoGenomics, Inc. | 1.92B | 3.65% | 1,161,476 | 745.97M |
| 290 | AGL | agilon health, inc. | 1.92B | 2.86% | 162,060 | 5.82B |
| 291 | DMRA | Damora Therapeutics, Inc. | 1.90B | 12.39% | 756,683 | - |
| 292 | SNDA | Sonida Senior Living, Inc. | 1.89B | 1.06% | 309,628 | 367.34M |
| 293 | PLSE | Pulse Biosciences, Inc. | 1.88B | -3.24% | 507,436 | 751.00K |
| 294 | MESO | Mesoblast Limited | 1.88B | 0.20% | 209,533 | 65.38M |
| 295 | GHRS | GH Research PLC | 1.86B | 0.93% | 465,368 | - |
| 296 | ZBIO | Zenas BioPharma, Inc. | 1.86B | 2.24% | 494,831 | 10.00M |
| 297 | CMPS | COMPASS Pathways plc | 1.84B | -2.54% | 2,697,990 | - |
| 298 | ALMR | Alamar Biosciences, Inc. | 1.83B | 4.27% | 152,771 | 87.16M |
| 299 | BHC | Bausch Health Companies Inc. | 1.81B | -1.12% | 1,143,623 | 10.53B |
| 300 | MPLT | MapLight Therapeutics, Inc. | 1.80B | 3.17% | 619,996 | - |
| 301 | MAZE | Maze Therapeutics, Inc. | 1.79B | 1.33% | 467,749 | 20.00M |
| 302 | ANIP | ANI Pharmaceuticals, Inc. | 1.77B | -1.56% | 220,896 | 923.71M |
| 303 | ATRC | AtriCure, Inc. | 1.75B | 2.58% | 777,422 | 552.16M |
| 304 | VIR | Vir Biotechnology, Inc. | 1.74B | -0.96% | 1,002,196 | 65.50M |
| 305 | COAG | Hemab Therapeutics Holdings, Inc. | 1.72B | 8.65% | 200,517 | - |
| 306 | SEPN | Septerna, Inc. | 1.70B | 3.54% | 876,063 | 72.26M |
| 307 | TRLV | Trulieve Cannabis Corp. | 1.69B | -1.24% | 970,126 | 1.17B |
| 308 | IMCR | Immunocore Holdings plc | 1.69B | -1.79% | 532,757 | 412.81M |
| 309 | FTRE | Fortrea Holdings Inc. | 1.67B | 3.76% | 703,959 | 2.71B |
| 310 | TDOC | Teladoc Health, Inc. | 1.66B | 1.32% | 2,112,450 | 2.51B |
| 311 | HCSG | Healthcare Services Group, Inc. | 1.66B | 1.00% | 386,356 | 1.85B |
| 312 | MLTX | MoonLake Immunotherapeutics | 1.65B | 4.59% | 1,361,100 | - |
| 313 | INVA | Innoviva, Inc. | 1.64B | -0.94% | 487,203 | 420.69M |
| 314 | INNV | InnovAge Holding Corp. | 1.61B | 2.69% | 115,415 | 949.17M |
| 315 | HROW | Harrow, Inc. | 1.60B | -4.86% | 457,515 | 268.68M |
| 316 | AAPG | Ascentage Pharma Group International | 1.60B | -1.38% | 8,835 | 82.08M |
| 317 | SVRA | Savara Inc. | 1.60B | -1.41% | 1,151,260 | - |
| 318 | AKTS | Aktis Oncology, Inc. | 1.57B | -0.96% | 327,575 | 8.28M |
| 319 | AVBP | ArriVent BioPharma, Inc. | 1.57B | 0.75% | 318,526 | - |
| 320 | KMTS | Kestra Medical Technologies, Ltd. | 1.56B | -0.37% | 290,782 | 83.72M |
| 321 | NVAX | Novavax, Inc. | 1.55B | 0.53% | 2,325,405 | 596.34M |
| 322 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.54B | 3.47% | 1,188,663 | 204.73M |
| 323 | PSNL | Personalis, Inc. | 1.54B | 3.97% | 5,202,023 | 64.52M |
| 324 | INBX | Inhibrx Biosciences, Inc. | 1.52B | 6.62% | 496,034 | 1.30M |
| 325 | CDNA | CareDx, Inc. | 1.50B | 5.70% | 527,608 | 412.82M |
| 326 | XERS | Xeris Biopharma Holdings, Inc. | 1.49B | -0.63% | 1,684,747 | 314.85M |
| 327 | INSP | Inspire Medical Systems, Inc. | 1.49B | 4.60% | 652,536 | 915.25M |
| 328 | ATEC | Alphatec Holdings, Inc. | 1.46B | 3.20% | 1,154,586 | 787.08M |
| 329 | ENOV | Enovis Corporation | 1.45B | 6.86% | 1,750,896 | 2.28B |
| 330 | ARDT | Ardent Health, Inc. | 1.44B | -0.69% | 292,691 | 6.43B |
| 331 | PRGO | Perrigo Company plc | 1.44B | -0.90% | 2,158,339 | 4.18B |
| 332 | IART | Integra LifeSciences Holdings Corporation | 1.43B | 6.30% | 698,508 | 1.64B |
| 333 | PNTG | The Pennant Group, Inc. | 1.41B | 3.42% | 287,240 | 1.02B |
| 334 | OMDA | Omada Health, Inc. | 1.40B | 2.26% | 835,530 | 283.30M |
| 335 | AHG | Akso Health Group | 1.39B | 1.25% | 772 | 14.84M |
| 336 | STAA | STAAR Surgical Company | 1.39B | -1.03% | 412,746 | 290.38M |
| 337 | BLFS | BioLife Solutions, Inc. | 1.38B | 3.57% | 365,716 | 101.66M |
| 338 | IMTX | Immatics N.V. | 1.36B | - | 215,066 | 43.00M |
| 339 | CRVS | Corvus Pharmaceuticals, Inc. | 1.36B | 0.44% | 898,960 | - |
| 340 | AHCO | AdaptHealth Corp. | 1.35B | 1.80% | 676,529 | 3.29B |
| 341 | JBIO | Jade Biosciences, Inc. | 1.34B | -0.11% | 542,790 | - |
| 342 | ARDX | Ardelyx, Inc. | 1.33B | -1.10% | 1,752,975 | 427.68M |
| 343 | PAHC | Phibro Animal Health Corporation | 1.32B | 0.49% | 128,017 | 1.50B |
| 344 | CAPR | Capricor Therapeutics, Inc. | 1.30B | 0.54% | 981,305 | 11.13M |
| 345 | AVLN | Avalyn Pharma Inc. | 1.29B | 0.45% | 196,249 | - |
| 346 | MGTX | MeiraGTx Holdings plc | 1.28B | -2.12% | 1,013,164 | 79.76M |
| 347 | MNKD | MannKind Corporation | 1.28B | -2.47% | 2,552,764 | 360.78M |
| 348 | SDGR | Schrödinger, Inc. | 1.25B | 4.35% | 560,647 | 254.91M |
| 349 | NUTX | Nutex Health Inc. | 1.25B | 1.36% | 107,811 | 879.95M |
| 350 | IRMD | IRADIMED CORPORATION | 1.25B | 1.43% | 35,093 | 86.28M |
| 351 | EYPT | EyePoint, Inc. | 1.24B | 5.71% | 1,359,764 | 7.61M |
| 352 | AMN | AMN Healthcare Services, Inc. | 1.22B | -1.71% | 570,525 | 3.42B |
| 353 | WVE | Wave Life Sciences Ltd. | 1.22B | 1.20% | 1,354,016 | 71.80M |
| 354 | XNCR | Xencor, Inc. | 1.19B | -2.13% | 591,747 | 97.36M |
| 355 | QDEL | QuidelOrtho Corporation | 1.19B | 1.22% | 896,618 | 2.66B |
| 356 | ALVO | Alvotech | 1.19B | -2.06% | 575,532 | 562.04M |
| 357 | SANA | Sana Biotechnology, Inc. | 1.18B | -1.51% | 2,004,253 | - |
| 358 | DRTS | Alpha Tau Medical Ltd. | 1.17B | 1.72% | 373,484 | - |
| 359 | AZTA | Azenta, Inc. | 1.17B | 3.71% | 435,800 | 596.48M |
| 360 | AORT | Artivion, Inc. | 1.17B | 2.33% | 294,925 | 458.69M |
| 361 | LMRI | Lumexa Imaging Holdings, Inc. | 1.17B | 0.08% | 277,467 | 1.03B |
| 362 | AVNS | Avanos Medical, Inc. | 1.17B | 0.06% | 203,172 | 715.90M |
| 363 | COLL | Collegium Pharmaceutical, Inc. | 1.16B | -0.20% | 330,265 | 796.33M |
| 364 | TRAX | First Tracks Biotherapeutics, Inc. | 1.14B | 57.29% | 4,256,904 | - |
| 365 | ORIC | ORIC Pharmaceuticals, Inc. | 1.13B | 0.46% | 676,747 | - |
| 366 | CGEM | Cullinan Therapeutics, Inc. | 1.12B | -0.68% | 385,099 | - |
| 367 | PRCT | PROCEPT BioRobotics Corporation | 1.12B | -0.28% | 1,173,425 | 322.02M |
| 368 | USPH | U.S. Physical Therapy, Inc. | 1.12B | 4.74% | 156,320 | 787.69M |
| 369 | SPTX | Seaport Therapeutics, Inc. | 1.12B | -1.93% | 137,668 | - |
| 370 | BIOA | BioAge Labs, Inc. | 1.11B | 5.37% | 504,885 | 10.32M |
| 371 | CNMD | CONMED Corporation | 1.11B | 9.38% | 1,025,883 | 1.37B |
| 372 | SLDB | Solid Biosciences Inc. | 1.09B | 0.59% | 788,038 | - |
| 373 | OLMA | Olema Pharmaceuticals, Inc. | 1.07B | 0.16% | 784,071 | - |
| 374 | VOR | Vor Biopharma Inc. | 1.07B | -2.76% | 1,405,179 | - |
| 375 | KURA | Kura Oncology, Inc. | 1.07B | -0.66% | 1,214,420 | 71.64M |
| 376 | TNDM | Tandem Diabetes Care, Inc. | 1.06B | 2.24% | 1,104,108 | 1.03B |
| 377 | CERT | Certara, Inc. | 1.06B | 3.98% | 2,005,657 | 419.75M |
| 378 | OPK | OPKO Health, Inc. | 1.05B | -1.06% | 2,585,473 | 581.12M |
| 379 | AVTX | Avalo Therapeutics, Inc. | 1.05B | 4.06% | 875,764 | 59.00K |
| 380 | CRON | Cronos Group Inc. | 1.03B | 1.27% | 1,013,470 | 159.54M |
| 381 | BVS | Bioventus Inc. | 1.02B | 1.16% | 510,242 | 576.30M |
| 382 | JANX | Janux Therapeutics, Inc. | 1.02B | 0.48% | 649,154 | 13.73M |
| 383 | ETON | Eton Pharmaceuticals, Inc. | 1.02B | 2.96% | 256,250 | 86.93M |
| 384 | EVO | Evotec SE | 1.01B | 2.52% | 11,018 | 859.03M |
| 385 | ABUS | Arbutus Biopharma Corporation | 1.01B | -1.72% | 2,509,518 | 191.45M |
| 386 | IVA | Inventiva S.A. | 1.01B | 2.73% | 1,719,086 | 7.94M |
| 387 | PHAR | Pharming Group N.V. | 1.01B | - | 3,168 | 369.49M |
| 388 | GERN | Geron Corporation | 1.00B | - | 10,778,546 | 196.12M |
| 389 | LXRX | Lexicon Pharmaceuticals, Inc. | 999.44M | -0.88% | 1,177,754 | 69.64M |
| 390 | PCRX | Pacira BioSciences, Inc. | 999.04M | -0.51% | 354,341 | 734.86M |
| 391 | GDRX | GoodRx Holdings, Inc. | 990.63M | -1.18% | 654,171 | 787.89M |
| 392 | ANRO | Alto Neuroscience, Inc. | 975.96M | 6.59% | 367,838 | - |
| 393 | ANNX | Annexon, Inc. | 972.41M | -0.42% | 1,732,999 | - |
| 394 | GLAS | Glass House Brands Inc. | 969.01M | -0.87% | 427,246 | 177.68M |
| 395 | PHAT | Phathom Pharmaceuticals, Inc. | 965.08M | 0.75% | 2,015,968 | 204.89M |
| 396 | DSGN | Design Therapeutics, Inc. | 964.96M | 1.11% | 578,077 | - |
| 397 | DBVT | DBV Technologies S.A. | 964.06M | -3.04% | 104,613 | 5.74M |
| 398 | LBRX | LB Pharmaceuticals Inc | 963.25M | -1.70% | 199,298 | - |
| 399 | INMD | InMode Ltd. | 950.70M | 3.77% | 1,514,057 | 374.64M |
| 400 | TENX | Tenax Therapeutics, Inc. | 937.53M | 3.50% | 1,433,112 | - |
| 401 | REPL | Replimune Group, Inc. | 932.63M | -0.09% | 2,272,494 | - |
| 402 | AVR | Anteris Technologies Global Corp. | 921.83M | -2.47% | 869,119 | 1.85M |
| 403 | FBRX | Forte Biosciences, Inc. | 903.14M | 79.59% | 4,646,168 | - |
| 404 | TBPH | Theravance Biopharma, Inc. | 880.56M | -0.06% | 344,642 | 109.78M |
| 405 | TALK | Talkspace, Inc. | 873.58M | -0.10% | 2,043,355 | 238.37M |
| 406 | CTMX | CytomX Therapeutics, Inc. | 855.57M | 2.61% | 1,614,727 | 35.54M |
| 407 | NGNE | Neurogene Inc. | 850.68M | 11.64% | 375,336 | 925.00K |
| 408 | GMRS | GMR Solutions Inc. | 845.82M | 0.51% | 391,297 | 5.83B |
| 409 | FTH | Faeth Therapeutics, Inc. | 841.68M | 16.52% | 149,769 | - |
| 410 | AMPH | Amphastar Pharmaceuticals, Inc. | 838.21M | 0.69% | 314,514 | 720.53M |
| 411 | OCS | Oculis Holding AG | 827.32M | - | 500,662 | 1.40M |
| 412 | ZVRA | Zevra Therapeutics, Inc. | 824.06M | -5.49% | 1,334,372 | 122.29M |
| 413 | ESPR | Esperion Therapeutics, Inc. | 820.75M | -0.16% | 53,137,391 | 418.24M |
| 414 | HSTM | HealthStream, Inc. | 812.77M | -1.28% | 111,836 | 311.78M |
| 415 | RIGL | Rigel Pharmaceuticals, Inc. | 812.24M | 2.26% | 250,197 | 299.77M |
| 416 | RGNX | REGENXBIO Inc. | 810.64M | 2.95% | 1,709,139 | 87.82M |
| 417 | ODTX | Odyssey Therapeutics, Inc. | 805.31M | 8.10% | 127,721 | 1.06M |
| 418 | ACRS | Aclaris Therapeutics, Inc. | 799.57M | 3.90% | 1,768,811 | 8.37M |
| 419 | CLYM | Climb Bio, Inc. | 790.77M | 1.77% | 1,082,754 | - |
| 420 | IMMX | Immix Biopharma, Inc. | 788.07M | 0.64% | 1,223,563 | - |
| 421 | SPRY | ARS Pharmaceuticals, Inc. | 780.52M | -2.96% | 876,014 | 98.99M |
| 422 | IRWD | Ironwood Pharmaceuticals, Inc. | 772.04M | -1.68% | 2,693,221 | 361.51M |
| 423 | AURA | Aura Biosciences, Inc. | 770.99M | -3.59% | 565,011 | - |
| 424 | SIBN | SI-BONE, Inc. | 767.02M | 2.40% | 477,767 | 206.22M |
| 425 | PRME | Prime Medicine, Inc. | 763.11M | -8.55% | 4,260,462 | 4.03M |
| 426 | GYRE | Gyre Therapeutics, Inc. | 753.66M | -1.46% | 49,680 | 117.05M |
| 427 | SSII | SS Innovations International, Inc. | 748.49M | 3.89% | 70,943 | 48.47M |
| 428 | OMER | Omeros Corporation | 745.10M | 0.54% | 758,002 | 9.89M |
| 429 | CSTL | Castle Biosciences, Inc. | 744.60M | 3.85% | 186,534 | 339.92M |
| 430 | CBLL | CeriBell, Inc. | 744.44M | 1.13% | 116,857 | 95.07M |
| 431 | SLBT | SL Science Holding Limited | 737.01M | 5.07% | 51,547 | - |
| 432 | BBNX | Beta Bionics, Inc. | 731.48M | 1.45% | 352,572 | 110.24M |
| 433 | ALLO | Allogene Therapeutics, Inc. | 724.82M | -0.94% | 5,630,674 | 22.00K |
| 434 | CADL | Candel Therapeutics, Inc. | 722.81M | -0.15% | 947,529 | - |
| 435 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 718.56M | -0.55% | 469,376 | - |
| 436 | MNPR | Monopar Therapeutics Inc. | 697.41M | 4.88% | 304,859 | - |
| 437 | TCMD | Tactile Systems Technology, Inc. | 692.14M | 2.35% | 80,667 | 343.52M |
| 438 | RLMD | Relmada Therapeutics, Inc. | 681.79M | 1.40% | 1,254,967 | - |
| 439 | CRMD | CorMedix Inc. | 681.35M | -1.64% | 621,976 | 400.05M |
| 440 | FDMT | 4D Molecular Therapeutics, Inc. | 673.32M | -1.08% | 477,693 | 88.24M |
| 441 | SGP | SpyGlass Pharma, Inc. | 672.68M | -1.66% | 114,970 | - |
| 442 | PHR | Phreesia, Inc. | 665.10M | 0.94% | 435,001 | 495.59M |
| 443 | DRUG | Bright Minds Biosciences Inc. | 663.93M | 11.32% | 199,709 | - |
| 444 | TECX | Tectonic Therapeutic, Inc. | 661.18M | -1.24% | 173,650 | - |
| 445 | ACHV | Achieve Life Sciences, Inc. | 658.04M | 3.22% | 1,393,616 | - |
| 446 | AGMB | AgomAb Therapeutics NV | 640.22M | 2.04% | 53,018 | - |
| 447 | DNA | Ginkgo Bioworks Holdings, Inc. | 634.95M | 7.17% | 919,995 | 151.40M |
| 448 | EVH | Evolent Health, Inc. | 633.83M | 0.63% | 1,436,675 | 1.89B |
| 449 | CERS | Cerus Corporation | 629.16M | - | 1,111,817 | 216.56M |
| 450 | MDXG | MiMedx Group, Inc. | 618.87M | -2.46% | 807,129 | 389.42M |
| 451 | BWAY | BrainsWay Ltd. | 606.60M | 0.67% | 66,023 | 56.22M |
| 452 | NVCT | Nuvectis Pharma, Inc. | 605.29M | 2.40% | 293,922 | - |
| 453 | ALT | Altimmune, Inc. | 604.81M | - | 2,526,527 | 36.00K |
| 454 | EIKN | Eikon Therapeutics, Inc. | 602.56M | 3.82% | 460,335 | - |
| 455 | KYTX | Kyverna Therapeutics, Inc. | 596.10M | -1.06% | 849,191 | - |
| 456 | FLGT | Fulgent Genetics, Inc. | 591.02M | 0.97% | 210,037 | 320.35M |
| 457 | CTKB | Cytek Biosciences, Inc. | 588.24M | 3.76% | 574,847 | 204.17M |
| 458 | TOI | The Oncology Institute, Inc. | 584.40M | 3.45% | 1,879,131 | 545.76M |
| 459 | CTNM | Contineum Therapeutics, Inc. | 582.29M | -0.48% | 236,437 | - |
| 460 | MYGN | Myriad Genetics, Inc. | 575.66M | 3.83% | 659,682 | 829.00M |
| 461 | NPCE | NeuroPace, Inc. | 574.48M | 0.42% | 75,815 | 99.53M |
| 462 | XOMA | XOMA Royalty Corporation | 562.47M | -0.33% | 330,117 | 48.56M |
| 463 | CBIO | Crescent Biopharma, Inc. | 555.92M | -0.48% | 111,327 | 11.88M |
| 464 | ASMB | Assembly Biosciences, Inc. | 552.50M | -2.96% | 151,956 | 71.10M |
| 465 | ARVN | Arvinas, Inc. | 551.01M | -0.23% | 358,441 | 89.40M |
| 466 | CTEV | Claritev Corporation | 548.43M | 0.47% | 57,612 | 978.76M |
| 467 | ANGO | AngioDynamics, Inc. | 539.78M | 1.09% | 204,814 | 313.73M |
| 468 | PROK | ProKidney Corp. | 539.18M | -2.99% | 1,212,749 | 889.00K |
| 469 | WEAV | Weave Communications, Inc. | 538.66M | 0.30% | 661,393 | 248.72M |
| 470 | STTK | Shattuck Labs, Inc. | 535.23M | 1.45% | 544,137 | 1.00M |
| 471 | RZLT | Rezolute, Inc. | 533.83M | 3.02% | 1,137,878 | - |
| 472 | CLPT | ClearPoint Neuro, Inc. | 533.81M | 2.95% | 297,469 | 40.61M |
| 473 | AQST | Aquestive Therapeutics, Inc. | 533.79M | -1.28% | 767,188 | 50.27M |
| 474 | ZURA | Zura Bio Limited | 523.91M | 0.46% | 1,004,837 | - |
| 475 | TLRY | Tilray Brands, Inc. | 523.06M | 0.34% | 2,744,960 | 858.28M |
| 476 | KIDS | OrthoPediatrics Corp. | 518.32M | 2.13% | 33,714 | 243.30M |
| 477 | NNNN | Anbio Biotechnology | 509.14M | 0.96% | 57,457 | 8.65M |
| 478 | CABA | Cabaletta Bio, Inc. | 507.92M | -0.48% | 5,872,989 | - |
| 479 | EDIT | Editas Medicine, Inc. | 504.89M | -10.35% | 3,193,603 | 38.69M |
| 480 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 481 | PRTA | Prothena Corporation plc | 503.90M | -2.28% | 378,070 | 57.94M |
| 482 | CYH | Community Health Systems, Inc. | 501.85M | 3.78% | 831,087 | 12.29B |
| 483 | PACB | Pacific Biosciences of California, Inc. | 496.96M | 6.67% | 5,700,075 | 160.03M |
| 484 | OCGN | Ocugen, Inc. | 495.93M | -2.33% | 4,313,617 | 4.47M |
| 485 | VALN | Valneva SE | 495.80M | - | 9,264 | 180.25M |
| 486 | STRO | Sutro Biopharma, Inc. | 495.46M | -6.09% | 205,327 | 99.61M |
| 487 | NRC | NRC Health | 491.30M | -0.32% | 50,031 | 138.64M |
| 488 | EVMN | Evommune, Inc. | 487.69M | 2.19% | 1,319,568 | 10.00M |
| 489 | SOPH | SOPHiA GENETICS SA | 485.75M | 5.08% | 356,729 | 81.18M |
| 490 | OVID | Ovid Therapeutics Inc. | 483.40M | -5.13% | 1,459,067 | 7.12M |
| 491 | PRLD | Prelude Therapeutics Incorporated | 482.00M | -5.08% | 275,596 | 16.72M |
| 492 | VSTM | Verastem, Inc. | 478.03M | 7.09% | 4,230,052 | 49.59M |
| 493 | CCCC | C4 Therapeutics, Inc. | 473.23M | 2.15% | 2,195,309 | 34.86M |
| 494 | VMD | Viemed Healthcare, Inc. | 469.63M | 0.91% | 215,080 | 286.57M |
| 495 | DCTH | Delcath Systems, Inc. | 467.42M | 3.36% | 278,240 | 90.44M |
| 496 | BNTC | Benitec Biopharma Inc. | 466.02M | 0.63% | 45,179 | - |
| 497 | OFIX | Orthofix Medical Inc. | 464.85M | -0.35% | 201,186 | 825.37M |
| 498 | SLN | Silence Therapeutics plc | 462.42M | -1.61% | 209,373 | 839.00K |
| 499 | ARTV | Artiva Biotherapeutics, Inc. | 460.62M | 1.83% | 227,451 | 251.00K |
| 500 | RCKT | Rocket Pharmaceuticals, Inc. | 455.88M | -1.53% | 1,884,161 | - |